BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
http://finance.yahoo.com/news/BioMarin-Agrees-to-Acquire-prnews-2279228346.html?x=0&.v=1
So sometimes hints on calls do pan out
.
I didn't catch the conference call. Will try to get a replay but if any one did (and anyone reads this board
) and wants to post comments would appreciate it.
http://finance.yahoo.com/news/BioMarin-Agrees-to-Acquire-prnews-2279228346.html?x=0&.v=1
So sometimes hints on calls do pan out
I didn't catch the conference call. Will try to get a replay but if any one did (and anyone reads this board
Recent BMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 09:01:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 05:17:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 05:59:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:07:23 PM
- BioMarin Reports First Quarter 2026 Financial and Operating Results • PR Newswire (US) • 05/04/2026 08:05:00 PM
- BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting • PR Newswire (US) • 05/02/2026 07:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 09:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 12:45:12 PM
- BioMarin Completes Acquisition of Amicus Therapeutics • PR Newswire (US) • 04/27/2026 12:44:00 PM
- BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET • PR Newswire (US) • 04/27/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 08:20:56 PM
- BioMarin Announces Board Leadership Transition • PR Newswire (US) • 04/21/2026 08:23:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:21:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:19:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:53:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:50:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:48:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:34:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 05:42:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:48:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:43:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 12:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 11:55:45 PM
- BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M • PR Newswire (US) • 03/12/2026 01:05:00 PM
